SSY Group (HKG:2005) obtained production and registration approval for the Propylthiouracil Tablets and Calcium Gluconate and Sodium Chloride Injection from China's National Medical Products Administration.
The move came as the drugs were regarded as passing the regulator's consistency evaluation, according to a Friday Hong Kong bourse filing.
The Propylthiouracil Tablets are mainly used for various types of hyperthyroidism intolerant to methimazole.
The Calcium Gluconate and Sodium Chloride Injection is used to treat acute hypocalcemia, magnesium poisoning, and fluoride poisoning, and has formed a calcium preparation product series along with the company's other products.